PALB2 and breast cancer: A study on the Dutch population showed, including the PRS313 in family history-based risk prediction, may change screening recommendations in up to 34 % of individuals from families with no pathogenic variants in any of the five breast cancer genes (BRCA1, BRCA1, PALB2, CHEK2, or ATM) modeled in BOADICEA.28